Evidence map›Paper›PMID 31784542›Full record

ArticleScientific reports2019

Isodeoxyelephantopin, a Sesquiterpene Lactone Induces ROS Generation, Suppresses NF-κB Activation, Modulates LncRNA Expression and Exhibit Activities Against Breast Cancer.

Sumit S Verma, Vipin Rai, Nikee Awasthee, Anupam Dhasmana, Dhanya S Rajalaksmi, Mangalam S Nair, Subash C Gupta

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Persianolide-A, an eudesmanolide-type sesquiterpene lactone fromResearch in pharmaceutical sciences · 2024
    Article
  8. Nanoscale advances · 2024
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sumit S VermaLaboratory for Translational Cancer Research, Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221 005, India.
Vipin RaiLaboratory for Translational Cancer Research, Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221 005, India.
Nikee AwastheeLaboratory for Translational Cancer Research, Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221 005, India.
Anupam DhasmanaSwami Rama Himalayan University, Jolly Grant, Dehradun, 248 016, India.
Dhanya S RajalaksmiDivision of Organic Chemistry, CSIR-National Institute for Interdisciplinary Science and Technology, Thiruvanantthapuram, India.
Mangalam S NairDivision of Organic Chemistry, CSIR-National Institute for Interdisciplinary Science and Technology, Thiruvanantthapuram, India.
Subash C GuptaLaboratory for Translational Cancer Research, Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221 005, India. sgupta@bhu.ac.in.
Banaras Hindu University · INNational Institute for Interdisciplinary Science and Technology · INSwami Rama Himalayan University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The sesquiterpene lactones, Isodeoxyelephantopin (IDET) and Deoxyelephantopin (DET) are known to exhibit activities against some cancer types. The activities of these lactones against breast cancer and the molecular bases is not known. We examined the efficacy of lactones in breast cancer preclinical model. Although both lactones exhibited drug like properties, IDET was relatively effective in comparison to DET. IDET suppressed the proliferation of both invasive and non-invasive breast cancer cell lines. IDET also suppressed the colony formation and migration of breast cancer cells. The assays for Acridine Orange (AO)/Propidium Iodide (PI) staining, cell cycle distribution, phosphatidylserine externalization and DNA laddering suggested the apoptosis inducing potential of IDET. The treatment with IDET also induced an accumulation of cells in the sub-G1 and G2/M phases. The exposure of breast cancer cells to the lactone was associated with a depolarization in mitochondrial membrane potential, and cleavage of caspase and PARP. The lactone induced reactive oxygen species (ROS) generation in breast cancer cells. Further, the use of N-acetyl cysteine (NAC) suppressed IDET induced ROS generation and apoptosis. The NF-κB-p65 nuclear translocation induced by okadaic acid (OA) was suppressed by the sesquiterpene. IDET also suppressed the expression of NF-κB regulated tumorigenic proteins, and induced the expression of proapoptotic gene (Bax) in cancer cells. While the expression of oncogenic lncRNAs was suppressed, the tumor suppressor lncRNAs were induced by the sesquiterpene. Collectively, the modulation of multiple cell signaling molecules by IDET may contribute to its activities in breast cancer cells.

Indexed as

Antineoplastic Agents, PhytogenicAsteraceaeBreast NeoplasmsCell ProliferationFemaleG2 Phase Cell Cycle CheckpointsGene Expression Regulation, NeoplasticHumansLactonesMembrane Potential, MitochondrialReactive Oxygen SpeciesRNA, Long NoncodingSesquiterpenesSignal TransductionStereoisomerismTranscription Factor RelAAntineoplastic Agents, PhytogenicdeoxyelephantopinisodeoxyelephantopinLactonesReactive Oxygen SpeciesRELA protein, humanRNA, Long NoncodingSesquiterpenesTranscription Factor RelA

Identifiers

PMID31784542
PMCPMC6884568
OpenAlexW2989795759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.